|
WO1981001145A1
(en)
|
1979-10-18 |
1981-04-30 |
Univ Illinois |
Hydrolytic enzyme-activatible pro-drugs
|
|
US4861719A
(en)
|
1986-04-25 |
1989-08-29 |
Fred Hutchinson Cancer Research Center |
DNA constructs for retrovirus packaging cell lines
|
|
GB8705477D0
(en)
|
1987-03-09 |
1987-04-15 |
Carlton Med Prod |
Drug delivery systems
|
|
US4975278A
(en)
|
1988-02-26 |
1990-12-04 |
Bristol-Myers Company |
Antibody-enzyme conjugates in combination with prodrugs for the delivery of cytotoxic agents to tumor cells
|
|
US5204244A
(en)
|
1987-10-27 |
1993-04-20 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5202238A
(en)
|
1987-10-27 |
1993-04-13 |
Oncogen |
Production of chimeric antibodies by homologous recombination
|
|
US5278056A
(en)
|
1988-02-05 |
1994-01-11 |
The Trustees Of Columbia University In The City Of New York |
Retroviral packaging cell lines and process of using same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
DE69434860T2
(de)
|
1993-02-22 |
2007-03-15 |
The Rockefeller University |
Herstellung von helfer-freien retroviren mit hohem titer mittels transienter transfektion
|
|
FR2712812B1
(fr)
|
1993-11-23 |
1996-02-09 |
Centre Nat Rech Scient |
Composition pour la production de produits thérapeutiques in vivo.
|
|
IL116816A
(en)
|
1995-01-20 |
2003-05-29 |
Rhone Poulenc Rorer Sa |
Cell for the production of a defective recombinant adenovirus or an adeno-associated virus and the various uses thereof
|
|
CN1241944C
(zh)
|
1995-09-11 |
2006-02-15 |
协和发酵工业株式会社 |
抗人白介素－5受体α链的抗体
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
ES2203782T3
(es)
|
1996-01-17 |
2004-04-16 |
Imperial College Innovations Limited |
Inmunoterapia que utiliza linfocitos t citotoxicos (ctl).
|
|
JP4972264B2
(ja)
|
1999-12-06 |
2012-07-11 |
ボード オブ トラスティーズ オブ ザ ユニバーシティ オブ イリノイ |
高親和性ｔｃｒタンパク質および方法
|
|
DE10225139A1
(de)
|
2002-05-29 |
2004-02-26 |
Immatics Biotechnologies Gmbh |
Verfahren zur Identifizierung von immunreaktiven Peptiden
|
|
US7751825B2
(en)
|
2002-06-27 |
2010-07-06 |
Qualcomm Incorporated |
Controlling geographic location information of devices operating in wireless communication systems
|
|
GB0308731D0
(en)
|
2003-04-15 |
2003-05-21 |
Anticancer Therapeutic Inv Sa |
Method of radiotherapy
|
|
JP2007519910A
(ja)
|
2004-01-28 |
2007-07-19 |
イマティクス バイオテクノロジーズ ゲーエムベーハー |
腫瘍関連ペプチドの同定および定量方法
|
|
CA2579558A1
(en)
*
|
2004-09-08 |
2006-03-16 |
Ludwig Institute For Cancer Research |
Cancer-testis antigens
|
|
US9840695B2
(en)
|
2009-04-28 |
2017-12-12 |
Agriculture Victoria Services Pty Ltd |
Plant technology
|
|
CA2777053A1
(en)
|
2009-10-06 |
2011-04-14 |
The Board Of Trustees Of The University Of Illinois |
Human single-chain t cell receptors
|
|
GB201006360D0
(en)
|
2010-04-16 |
2010-06-02 |
Immatics Biotechnologies Gmbh |
Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development
|
|
AU2013295652B2
(en)
|
2012-07-27 |
2018-02-08 |
The Board Of Trustees Of The University Of Illinois |
Engineering T-cell receptors
|
|
SI2932264T1
(sl)
*
|
2012-12-14 |
2019-05-31 |
Biontech Rna Pharmaceuticals Gmbh |
Novi MHC-neodvisni, s tumorjem povezani antigeni
|
|
GB201423361D0
(en)
|
2014-12-30 |
2015-02-11 |
Immatics Biotechnologies Gmbh |
Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides
|
|
US11261223B2
(en)
|
2016-05-11 |
2022-03-01 |
The University Of Chicago |
Methods of treating cancers with CT45 targeted therapies
|
|
DE102016123893A1
(de)
|
2016-12-08 |
2018-06-14 |
Immatics Biotechnologies Gmbh |
T-Zellrezeptoren mit verbesserter Bindung
|
|
SG11202000025SA
(en)
|
2017-07-14 |
2020-02-27 |
Immatics Biotechnologies Gmbh |
Improved dual specificity polypeptide molecule
|
|
US20220175899A1
(en)
|
2019-04-11 |
2022-06-09 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cytotoxic t lymphocytes specific for mutated forms of epidermal growth factor receptor for use in treating cancer
|